Kestra Medical Technologies, Ltd.
KMTS
$20.70
$1.115.67%
NASDAQ
| 01/31/2026 | 10/31/2025 | 07/31/2025 | 04/30/2025 | 01/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 62.70% | 53.40% | 51.55% | 71.40% | 82.31% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 62.70% | 53.40% | 51.55% | 71.40% | 82.31% |
| Cost of Revenue | 36.32% | 25.46% | 22.58% | 10.89% | 15.49% |
| Gross Profit | 97.13% | 95.95% | 110.74% | 446.39% | 643.98% |
| SG&A Expenses | 79.45% | 78.52% | 75.42% | 181.50% | 39.23% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 66.20% | 60.50% | 54.58% | 115.26% | 26.46% |
| Operating Income | -68.75% | -65.96% | -56.68% | -136.93% | -3.28% |
| Income Before Tax | -56.99% | -58.89% | -26.96% | -128.63% | -0.63% |
| Income Tax Expenses | 94.44% | 325.00% | 371.43% | 477.78% | 28.57% |
| Earnings from Continuing Operations | -57.02% | -58.99% | -27.08% | -129.36% | -0.65% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -58.85% | -60.96% | -29.88% | -133.59% | 0.51% |
| EBIT | -68.75% | -65.96% | -56.68% | -136.93% | -3.28% |
| EBITDA | -75.18% | -70.18% | -67.23% | -175.28% | -12.84% |
| EPS Basic | 51.01% | 46.44% | 55.05% | -84.39% | -5.98% |
| Normalized Basic EPS | 43.05% | 37.27% | 49.03% | -106.96% | 1.21% |
| EPS Diluted | 51.01% | 46.44% | 55.05% | -84.39% | -5.98% |
| Normalized Diluted EPS | 43.05% | 37.27% | 49.03% | -106.96% | 1.21% |
| Average Basic Shares Outstanding | 180.85% | 158.36% | 158.00% | 23.63% | 0.00% |
| Average Diluted Shares Outstanding | 180.85% | 158.36% | 158.00% | 23.63% | 0.00% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |